首页 | 本学科首页   官方微博 | 高级检索  
     

Aurora激酶抑制剂研究进展
引用本文:冷 莹,袁浩亮,张微微,陈亚东,陆 涛. Aurora激酶抑制剂研究进展[J]. 药学与临床研究, 2012, 20(3): 211-217
作者姓名:冷 莹  袁浩亮  张微微  陈亚东  陆 涛
作者单位:中国药科大学基础部分子设计与药物发现实验室,南京,210009
摘    要:Aurora激酶是细胞有丝分裂相关的一类丝氧酸/苏氨酸激酶,在细胞周期调控中起着重要的作用,研究发现Aurora激酶在多数血液恶性肿瘤和实体瘤中均高表达,表明Aurora激酶是抗肿瘤药物研究的重要新靶点之一.本文主要围绕Aurora家族的三个成员,对其生物学功能及其与肿瘤的关系、抑制剂的研究进展及其研究策略进行综述.

关 键 词:Aurora激酶  有丝分裂  Aurora激酶抑制剂  癌症治疗
收稿时间:2012-03-05
修稿时间:2012-03-15

Progress in the Development of Aurora Kinase Inhibitors
LENG Ying,YUAN Hao-liang,ZHANG Wei-wei,CHEN Ya-dong and LU Tao. Progress in the Development of Aurora Kinase Inhibitors[J]. Pharmacertical and Clinical Research, 2012, 20(3): 211-217
Authors:LENG Ying  YUAN Hao-liang  ZHANG Wei-wei  CHEN Ya-dong  LU Tao
Affiliation:Laboratory of Molecular Design and Drug Discovery,School of Basic Sciences,China Pharmaceutical University,Nanjing 210009,China
Abstract:Aurora kinases belong to serine/threonine kinase family,which are involved in cellular mitosis affecting the process of cell cycle.Several studies have shown amplification and/or over-expression of Aurora kinase in hematologic malignancies and solid tumors,suggesting they are important targets for anti-cancer drugs.This review summarized the biological functions of Aurora kinases,their relationship with tumor,the progresses and development strategy of Aurora kinase inhibitors.
Keywords:Aurora kinase  Mitosis  Aurora kinase inhibitors  Cancer therapy
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《药学与临床研究》浏览原始摘要信息
点击此处可从《药学与临床研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号